Literature DB >> 11835417

Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy.

J R McMinn1, J N George.   

Abstract

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) is more common in women, and commonly occurs during pregnancy and the immediate postpartum period. An important clinical issue is the distinction of TTP-HUS from the more common obstetric complications, preeclampsia and HELLP syndrome (hemolysis, elevated liver function tests, low platelets). Clinical suspicion of TTP-HUS requires urgent intervention with plasma exchange treatment, a procedure with substantial risk, while preeclampsia and HELLP syndrome typically resolve spontaneously following delivery. Since clinical features of these syndromes can be similar, especially if preeclampsia becomes severe or if seizures (defining eclampsia) occur, the differential diagnosis may be arbitrary. This review addresses the evaluation and management of these syndromes and describes a clinical approach for determining when plasma exchange is appropriate. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11835417     DOI: 10.1002/jca.10005

Source DB:  PubMed          Journal:  J Clin Apher        ISSN: 0733-2459            Impact factor:   2.821


  18 in total

1.  Von Willebrand factor antigen and ADAMTS13 activity assay in pregnant women and severe preeclamptic patients.

Authors:  Dandan Zhang; Juan Xiao; Haoliang Huang; Juanjuan Chen; Tao Liu; Zongzhi Yin; Danping Gao; Qiong Liu; Jihui Ai; Suhua Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-12-22

Review 2.  Thrombocytopenia in pregnancy.

Authors:  Douglas B Cines; Lisa D Levine
Journal:  Blood       Date:  2017-06-21       Impact factor: 22.113

3.  Eculizumab in pregnancy-associated atypical hemolytic uremic syndrome: insights for optimizing management.

Authors:  Erika De Sousa Amorim; Miquel Blasco; Luis Quintana; Manel Sole; Santiago Rodríguez de Cordoba; Josep Maria Campistol
Journal:  J Nephrol       Date:  2015-02-25       Impact factor: 3.902

4.  Successful outcome of therapeutic plasma exchange in post-partum haemolytic-uraemic syndrome: a case report.

Authors:  Surbhi Dixit; Aseem Kumar Tiwari; Prashant Kumar Pandey; Vimarsh Raina
Journal:  Blood Transfus       Date:  2012-10       Impact factor: 3.443

Review 5.  Thrombotic thrombocytopenic purpura: survival by "giving a dam".

Authors:  Joel L Moake
Journal:  Trans Am Clin Climatol Assoc       Date:  2004

6.  A STARD-compliant prediction model for diagnosing thrombotic microangiopathies.

Authors:  Pietro Manuel Ferraro; Gianmarco Lombardi; Alessandro Naticchia; Antonio Sturniolo; Cecilia Zuppi; Valerio De Stefano; Patrizia Bonelli; Ruggero Buonocore; Gianfranco Cervellin; Giuseppe Lippi; Giovanni Gambaro
Journal:  J Nephrol       Date:  2018-01-20       Impact factor: 3.902

Review 7.  Thrombocytopenia in pregnancy.

Authors:  Douglas B Cines; Lisa D Levine
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

8.  Cerebral vasospasm and intracerebral haemorrhage in a case of pregnancy-related thrombotic thrombocytopoenic purpura/haemolytic uraemic syndrome.

Authors:  I C Duncan
Journal:  Interv Neuroradiol       Date:  2005-10-25       Impact factor: 1.610

9.  Variant-specific quantification of factor H in plasma identifies null alleles associated with atypical hemolytic uremic syndrome.

Authors:  Svetlana Hakobyan; Agustín Tortajada; Claire L Harris; Santiago R de Córdoba; Bryan P Morgan
Journal:  Kidney Int       Date:  2010-08-11       Impact factor: 10.612

Review 10.  Immune thrombocytopenia in pregnancy.

Authors:  Evi Stavrou; Keith R McCrae
Journal:  Hematol Oncol Clin North Am       Date:  2009-12       Impact factor: 3.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.